Search

Cancer care for adolescents and young adults (AYAs) requires a unique approach. Patients in this age group (15-25 years) face specific challenges that set them apart from both paediatric and older adult cancer patients,... Read more

We base our partnerships strategy on the knowledge that nothing but the best is good enough in cancer care.We partner with local and global networks of institutions, industries and communities to improve the quality of cancer... Read more

Updated results from a Peter Mac-led international clinical trial have shown how a new drug represents a “remarkable advancement in lung cancer”. Five-year, progression-free-survival data has just been published for the... Read more

Peter Mac’s Research Flow Core has been internationally recognised for its excellent operations and adherence to best practices in flow cytometry. Presented at the recent International Society for the Advancement of... Read more

With a focus on developing new therapeutic strategies to improve outcomes for blood cancer patients, our goal is to contribute along each stage of the biomedical research spectrum - from understanding fundamental oncogenic... Read more

Over one million Australians are living with or beyond their cancer diagnosis. This is due to advances in early detection, better treatments, and the ageing of the population. Cancer survivorship care refers to the time... Read more